Gabriel López-Velázquez

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

International journal of molecular sciences

Medicine

Scientific reports

Applied microbiology and biotechnology

Universidad Nacional Autónoma de México (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidad Nacional Autónoma de México

Mexico

PHD

Publications

Carlos Gaona-López, Domingo Méndez-Álvarez, Adriana Moreno-Rodríguez, Juan Luis Bautista-Martínez, José Antonio De Fuentes-Vicente, Benjamín Nogueda-Torres, Itzhel García-Torres, Gabriel López-Velázquez, Gildardo Rivera
TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents. International journal of molecular sciences 25 (11) (2024)
Carlos Gaona-López, Domingo Méndez-Álvarez, Adriana Moreno-Rodríguez, Juan Luis Bautista-Martínez, José Antonio De Fuentes-Vicente, Benjamín Nogueda-Torres, Itzhel García-Torres, Gabriel López-Velázquez, Gildardo Rivera
TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents. International journal of molecular sciences 25 (11) (2024)
Carlos Gaona-López, Domingo Méndez-Álvarez, Adriana Moreno-Rodríguez, Juan Luis Bautista-Martínez, José Antonio De Fuentes-Vicente, Benjamín Nogueda-Torres, Itzhel García-Torres, Gabriel López-Velázquez, Gildardo Rivera
TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents. International journal of molecular sciences 25 (11) (2024)
Sergio Enríquez-Flores, José Ignacio De la Mora-De la Mora, Itzhel García-Torres, Luis A Flores-López, Yoalli Martínez-Pérez, Gabriel López-Velázquez
Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational Modifications. Molecules (Basel, Switzerland) 28 (16) (2023)
Itzhel García-Torres, José Ignacio De la Mora-De la Mora, Gabriel López-Velázquez, Nallely Cabrera, Luis Antonio Flores-López, Ingeborg Becker, Juliana Herrera-López, Roberto Hernández, Ruy Pérez-Montfort, Sergio Enríquez-Flores
Repurposing of rabeprazole as an anti- Trypanosoma cruzi drug that targets cellular triosephosphate isomerase. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Cynthia Fernández-Lainez, José Ignacio De la Mora-De la Mora, Sergio Enríquez-Flores, Itzhel García-Torres, Luis A Flores-López, Pedro Gutiérrez-Castrellón, Paul de Vos, Gabriel López-Velázquez
The Giardial Arginine Deiminase Participates in Giardia -Host Immunomodulation in a Structure-Dependent Fashion via Toll-like Receptors. International journal of molecular sciences 23 (19) (2022)
Sergio Enríquez-Flores, José Ignacio De la Mora-De la Mora, Luis Antonio Flores-López, Nallely Cabrera, Cynthia Fernández-Lainez, Gloria Hernández-Alcántara, Carlos Enrique Guerrero-Beltrán, Gabriel López-Velázquez, Itzhel García-Torres
Improved yield, stability, and cleavage reaction of a novel tobacco etch virus protease mutant. Applied microbiology and biotechnology 106 (4) (2022)
Chiharu Murata, Pedro Gutiérrez-Castrellón, Fernando Pérez-Villatoro, Itzhel García-Torres, Sergio Enríquez-Flores, Ignacio de la Mora-de la Mora, Cynthia Fernández-Lainez, Julieta Werner, Gabriel López-Velázquez
Delivery mode-associated gut microbiota in the first 3 months of life in a country with high obesity rates: A descriptive study. Medicine 99 (40) (2020)
Gabriel López-Velázquez, Cynthia Fernández-Lainez, José Ignacio de la Mora-de la Mora, Daniela Caudillo de la Portilla, Rafael Reynoso-Robles, Angélica González-Maciel, Cecilia Ridaura, Itzhel García-Torres, Pedro Gutiérrez-Castrellón, Alfonso Olivos-García, Luis Antonio Flores-López, Sergio Enríquez-Flores
On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug. Scientific reports 9 (1) (2019)

Gabriel López-Velázquez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gabriel López-Velázquez